MREO vs JNJ: Which Stock is Better?
Side-by-side comparison of Mereo Biopharma Group Plc and Johnson & Johnson in 2026
MREO
Mereo Biopharma Group Plc
$0.57
JNJ
Johnson & Johnson
$218.21
Key Metrics Comparison
| Metric | MREO | JNJ | Winner |
|---|---|---|---|
| Market Cap | $89.93M | $525.73B | JNJ |
| P/E Ratio | N/A | 21.10 | JNJ |
| EPS (TTM) | $N/A | $10.34 | JNJ |
| Revenue Growth | 0.0% | 0.1% | JNJ |
| Gross Margin | 73.4% | 68.4% | MREO |
Analyze MREO
Full quant analysis
Analyze JNJ
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is MREO or JNJ a better investment?
Comparing MREO and JNJ: Mereo Biopharma Group Plc has a market cap of $89.93M while Johnson & Johnson has $525.73B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between MREO and JNJ?
MREO (Mereo Biopharma Group Plc) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: MREO or JNJ?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: MREO or JNJ?
JNJ has higher revenue growth at 0.1% vs 0.0% for MREO.
Which company is more profitable: MREO or JNJ?
Mereo Biopharma Group Plc (MREO) has higher gross margins at 73.4% compared to 68.4% for JNJ.
Which is the larger company: MREO or JNJ?
Johnson & Johnson (JNJ) is larger with a market cap of $525.73B compared to $89.93M for MREO.
Should I buy MREO or JNJ in 2026?
Both MREO and JNJ have investment merit. MREO trades at $0.57 while JNJ trades at $218.21. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between MREO and JNJ stock?
Key differences: Market Cap ($89.93M vs $525.73B), P/E Ratio (N/A vs 21.1x), Revenue Growth (0.0% vs 0.1%), Gross Margin (73.4% vs 68.4%).